Compare PSIX & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSIX | QDEL |
|---|---|---|
| Founded | 1985 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | N/A | N/A |
| Metric | PSIX | QDEL |
|---|---|---|
| Price | $77.15 | $28.26 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 6 |
| Target Price | ★ $98.76 | $40.00 |
| AVG Volume (30 Days) | 397.5K | ★ 950.8K |
| Earning Date | 02-08-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 122.27 | N/A |
| EPS | ★ 5.26 | N/A |
| Revenue | $675,481,000.00 | ★ $2,714,400,000.00 |
| Revenue This Year | $50.35 | N/A |
| Revenue Next Year | $20.10 | $2.42 |
| P/E Ratio | $14.69 | ★ N/A |
| Revenue Growth | ★ 54.78 | N/A |
| 52 Week Low | $18.10 | $19.50 |
| 52 Week High | $121.78 | $46.24 |
| Indicator | PSIX | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 62.66 | 41.25 |
| Support Level | $72.66 | $27.19 |
| Resistance Level | $80.00 | $35.58 |
| Average True Range (ATR) | 4.76 | 2.18 |
| MACD | 1.15 | -0.59 |
| Stochastic Oscillator | 85.17 | 13.42 |
Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States.
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.